跳至主要内容
临床试验/NCT03158467
NCT03158467撤回不适用

A Pilot Randomized Control Trial of Advance Care Planning and Triggered Palliative Care for Cancer Patients Undergoing Stem Cell Transplantation (RCT of ACP for Transplant)

Abramson Cancer Center at Penn Medicine0 个研究点开始时间: 2017年5月15日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
Number of surveys completed

研究概览

简要总结

We aim to examine the effect of an online advance directive on decisional conflict and quality of life in patients undergoing stem cell transplant. We also aim to assess the effect of palliative care at the time of a sentinel event on quality of life.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The inclusion criteria for Phase I (primary objective) are as follows:
  • Age ≥ 18 years
  • Hematologic malignancy diagnosis including any subset of myeloma, lymphoma, leukemia, or myelodysplastic syndrome
  • Currently scheduled for autologous or allogeneic transplant at the Hospital of the University of Pennsylvania
  • The inclusion criteria for Phase II (secondary objective) are as follows:
  • Age ≥ 18 years
  • Hematologic malignancy diagnosis including any subset of lymphoma, leukemia, or myelodysplastic syndrome
  • Received an autologous or allogeneic stem cell transplant at the Hospital of the University of Pennsylvania and experienced a sentinel event of either 1) disease relapse,2) severe (Grade III or IV) graft-versus-host disease, or 3) unplanned hospital admission with length of stay greater than 72 hours.

排除标准

  • The exclusion criteria for Phase I include:
  • Inability to read and write English
  • Not serving as the primary decision maker for their health-related decisions
  • Having a non-hematologic malignancy reason for undergoing transplantation (e.g. aplastic anemia)
  • The exclusion criteria for Phase II include:
  • Not completing participation in Phase I of the study
  • Myeloma diagnosis

结局指标

主要结局

Number of surveys completed

时间窗: 2 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验